302 related articles for article (PubMed ID: 9006370)
1. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
3. [Stage-oriented treatment of Lyme borreliosis].
Fingerle V; Wilske B
MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
[TBL] [Abstract][Full Text] [Related]
4. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
[TBL] [Abstract][Full Text] [Related]
5. Lyme disease: the evolution of erythema chronicum migrans into acrodermatitis chronica atrophicans.
Patmas MA
Cutis; 1993 Sep; 52(3):169-70. PubMed ID: 8243101
[TBL] [Abstract][Full Text] [Related]
6. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
Aberer E; Bergmann AR; Derler AM; Schmidt B
Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
[TBL] [Abstract][Full Text] [Related]
7. [Borrelia infections of the skin--progress of knowledge since the discovery of Lyme disease].
Garbe C
Hautarzt; 1991 Jun; 42(6):356-65. PubMed ID: 1917458
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria.
Glatz M; Resinger A; Semmelweis K; Ambros-Rudolph CM; Müllegger RR
Acta Derm Venereol; 2015 May; 95(5):565-71. PubMed ID: 25366035
[TBL] [Abstract][Full Text] [Related]
9. [Etiology of acrodermatitis chronica atrophicans and erythema chronicum migrans].
Herrmann WP
Z Hautkr; 1986 Apr; 61(8):515-21. PubMed ID: 3521114
[TBL] [Abstract][Full Text] [Related]
10. Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases.
Lenormand C; Jaulhac B; Debarbieux S; Dupin N; Granel-Brocard F; Adamski H; Barthel C; Cribier B; Lipsker D
J Am Acad Dermatol; 2016 Apr; 74(4):685-92. PubMed ID: 26781226
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations of Lyme borreliosis.
Aberer E; Klade H
Infection; 1991; 19(4):284-6. PubMed ID: 1917047
[TBL] [Abstract][Full Text] [Related]
12. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
Svecová D; Buchvald J; Oprsalová K; Dolezalová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):115-22. PubMed ID: 11040493
[TBL] [Abstract][Full Text] [Related]
13. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.
Asbrink E
Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647
[TBL] [Abstract][Full Text] [Related]
14. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
Fürst B; Glatz M; Kerl H; Müllegger RR
Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans.
Müllegger RR; McHugh G; Ruthazer R; Binder B; Kerl H; Steere AC
J Invest Dermatol; 2000 Dec; 115(6):1115-23. PubMed ID: 11121150
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of skin manifestations of Lyme disease in Croatia].
Kansky A; Balić-Winter A; Bolanca-Bumber S; Skerlev M
Lijec Vjesn; 1992; 114(1-4):25-7. PubMed ID: 1343019
[TBL] [Abstract][Full Text] [Related]
17. Lyme borreliosis.
Scarpa C; Trevisan G; Stinco G
Dermatol Clin; 1994 Oct; 12(4):669-85. PubMed ID: 7805296
[TBL] [Abstract][Full Text] [Related]
18. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays.
Asbrink E; Hovmark A; Hederstedt B
Acta Derm Venereol; 1985; 65(6):509-14. PubMed ID: 2420115
[TBL] [Abstract][Full Text] [Related]
19. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.
Wienecke R; Zöchling N; Neubert U; Schlüpen EM; Meurer M; Volkenandt M
J Invest Dermatol; 1994 Jul; 103(1):19-22. PubMed ID: 8027576
[TBL] [Abstract][Full Text] [Related]
20. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
